
Loading, please wait...

Loading, please wait...

Rheumatoid arthritis (RA) is a chronic autoimmune condition that leads to joint destruction. However, smoking remains the most critical modifiable risk factor. A recent analysis using the Global Burden of Disease (GBD) 2021 data highlights the significant **RA smoking burden** worldwide. Although age-standardized rates are declining, absolute numbers continue to rise. Because of this trend, public health experts are calling for more targeted tobacco control strategies.
According to the 2021 GBD study, global deaths from smoking-attributable RA increased by over 26% since 1990. In addition, disability-adjusted life years (DALYs) rose by nearly 50%. Specifically, researchers recorded 2,264 deaths in 2021. Furthermore, the total DALYs reached 215,780. Consequently, the absolute weight of this disease on global healthcare is heavier than ever before. Therefore, healthcare providers must recognize that a decline in rates does not mean a decline in cases.
Indeed, the age-standardized death rate fell from 0.05 to 0.03 per 100,000. Nevertheless, population growth and aging keep the total burden high. For instance, forecasts through 2050 predict continued increases in absolute mortality. Because population aging is accelerating, the number of elderly patients with RA will grow. Similarly, middle-to-high SDI regions continue to report a higher burden compared to lower SDI regions.
Moreover, the impact of smoking on RA is not uniform across genders. Males experience a significantly higher burden. In fact, males had 2.42 times more deaths than females in 2021. Likewise, they accounted for 1.68 times more DALYs. This disparity exists because of historically higher smoking rates among men. Additionally, the risk increases with age. As a result, older males are the highest-risk group for smoking-attributable RA disability.
Smoking does not just cause RA; it also makes it harder to treat. For example, methotrexate is a mainstay drug for RA management. However, many studies show that smoking reduces its efficacy. Furthermore, smoking limits the response to advanced biologic therapies like anti-TNF drugs. Because of these pharmacological interactions, smokers often suffer from more severe joint damage. Thus, cessation is not just a general health goal but a clinical necessity for RA patients.
In India, the overall burden of RA is also on the rise. Specifically, the prevalence is high among women, but the **RA smoking burden** primarily affects the growing population of male smokers. Because India has a high prevalence of tobacco use, the interplay between environmental factors and genetics is crucial. Therefore, national health programs should integrate rheumatology awareness into existing tobacco control initiatives.
Tobacco smoke can alter the metabolism of drugs like methotrexate. Consequently, smokers may require higher doses or switch to more expensive biologics to achieve remission.
Yes. Although joint damage is often permanent, quitting smoking reduces systemic inflammation. As a result, many patients experience fewer flare-ups and better long-term outcomes.
The total number of cases is rising because the global population is growing and aging. Therefore, even though a smaller percentage of people smoke, the total number of individuals with RA remains high.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
Wu Y et al. Global burden and trends of rheumatoid arthritis attributable to smoking from 1990 to 2021 with forecasts to 2050. Trop Med Health. 2026 Feb 14. doi: 10.1186/s41182-026-00921-x. PMID: 41691352.
Shi H et al. Burden of rheumatoid arthritis in India from 1990 to 2021: insights from the Global Burden of Disease Database. Front Med (Lausanne). 2025 Feb 14;12:1526218.
Arthritis Foundation. Smoking Can Be Hazardous to Your Joints. April 2023.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A detailed analysis of the rising global RA smoking burden based on GBD 2021 data, including Indian context and the impact of tobacco on treatment response....
5 months ago

Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today

A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Yesterday

A comprehensive meta-analysis shows digital health technologies significantly improve 6-minute walk distance and peak oxygen uptake in chronic heart failure patients, highlighting the clinical promise of structured remote cardiac rehabilitation.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

A comprehensive analysis of continuous glucose monitoring systems under European Medical Device Regulation 2017/745, examining conformity assessment challenges, Notified Body backlogs, EUDAMED rollout delays, and the critical need for transparent post-market surveillance.
Today